PCW-A1001
Pre-clinical- Indications
- Acute myeloid leukemia
Company intelligence / Profile preview
PharmCADD
Busan, South Koreapharmcadd.com ↗
- Ownership
- Private
- Employees
- ~53
- Development stage
- Preclinical
01
Overview
PharmCADD develops advanced computational platforms integrating artificial intelligence and quantum physics to accelerate drug discovery. Its proprietary technologies—such as Pharmulator and PharmVAC—enable rapid identification of novel small molecules and mRNA vaccines. The company has validated its approach through multiple licensing deals with major Korean pharmaceutical companies. Its lead asset appears to be an AI-assisted mRNA COVID‑19 vaccine currently in a global Phase IIa trial; the broader pipeline includes more than ten programs across oncology, autism spectrum disorder, blood anticoagulation/thrombosis prevention/treatment and infectious diseases like COVID‑19.
- Therapeutic areas
- OncologyPsychiatryInfectious DiseasesHematology
- Modalities
- Small moleculemRNA-based drugsPROTAC (Proteolysis-targeting chimera therapy)RNA therapyPeptidesDrug delivery system therapies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Multiple licensing agreements with major domestic South Korean pharmaceutical companies for technology validation/licensing-out contracts. Specific partners not named publicly.
Beyond the preview
Go deeper on PharmCADD.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PharmCADD.